From: Long-term outcome in new onset refractory status epilepticus: a retrospective study
Number of AEDs (median[IQR]) | 5 [4–7] |
Duration of treatment with anesthetic agents (days, median[IQR]) | 8 [6–18] |
Need of invasive mechanical ventilation, n (%) | 24 (96) |
Duration of invasive mechanical ventilation (days, median[IQR]) | 17 [9–25] |
Need of vasopressor support, n (%) | 18 (72) |
Duration of vasopressor support (days, median[IQR]) | 7 [1–16] |
Need of tracheostomy, n (%) | 15 (60) |
ICU complications, n (%) | 25 (100) |
Neurological, n (%) | 18 (72) |
Delirium | 5 |
Neurocognitive deficits | 13 |
Focal deficits | 3 |
CIP/CIM | 9 |
Infections, n (%) | 18 (72) |
VAP | 13 |
UTI | 8 |
CRBSI | 2 |
Respiratory, n (%) | 16 (64) |
Aspiration pneumonia | 6 |
ARDS | 2 |
Atelectasis | 3 |
Others | 6 |
Metabolic, n (%) | 14 (56) |
Gastrointestinal, n (%) | 10 (40) |
Cardiac, n (%) | 9 (36) |
Arrhythmia | 8 |
NSTEMI | 1 |
Length of stay on ICU (days, median[IQR]) | 21 [18–31] |
Length of stay in hospital (days, median[IQR]) | 39 [26–55] |